Lynn L. Barron

1.0k total citations
27 papers, 637 citations indexed

About

Lynn L. Barron is a scholar working on Genetics, Immunology and Molecular Biology. According to data from OpenAlex, Lynn L. Barron has authored 27 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 11 papers in Immunology and 9 papers in Molecular Biology. Recurrent topics in Lynn L. Barron's work include Chronic Lymphocytic Leukemia Research (16 papers), Immunodeficiency and Autoimmune Disorders (10 papers) and Lymphoma Diagnosis and Treatment (9 papers). Lynn L. Barron is often cited by papers focused on Chronic Lymphocytic Leukemia Research (16 papers), Immunodeficiency and Autoimmune Disorders (10 papers) and Lymphoma Diagnosis and Treatment (9 papers). Lynn L. Barron collaborates with scholars based in United States, Germany and Netherlands. Lynn L. Barron's co-authors include Merle S. Olson, Michael J. Keating, Lynne V. Abruzzo, Kevin R. Coombes, Tarun B. Patel, William G. Wierda, Alessandra Ferrajoli, R K Hampson, Denis B. Buxton and Michael S. DeBuysere and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Bioinformatics.

In The Last Decade

Lynn L. Barron

26 papers receiving 620 citations

Peers

Countries citing papers authored by Lynn L. Barron

Since Specialization

Citations

This map shows the geographic impact of Lynn L. Barron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn L. Barron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn L. Barron more than expected).

Fields of papers citing papers by Lynn L. Barron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn L. Barron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn L. Barron. The network helps show where Lynn L. Barron may publish in the future.

Co-authorship network of co-authors of Lynn L. Barron

This figure shows the co-authorship network connecting the top 25 collaborators of Lynn L. Barron. A scholar is included among the top collaborators of Lynn L. Barron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynn L. Barron. Lynn L. Barron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Time-to-progression after front-line fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy for chronic lymphocytic leukaemia: a retrospective, multicohort study 2019 ·The Lancet Oncology ·Carmen Herling, Kevin R. Coombes, Axel Benner, Johannes Bloehdorn, Lynn L. Barron, Zachary B. Abrams, Tadeusz Majewski, Jolanta Bondaruk, Jasmin Bahlo, Kirsten Fischer, Michael Hallek, Stephan Stilgenbauer, Bogdan Czerniak, Christopher C. Oakes, Alessandra Ferrajoli, Michael J. Keating, Lynne V. Abruzzo	15
2	Trisomy 12 chronic lymphocytic leukemia expresses a unique set of activated and targetable pathways 2018 ·Haematologica ·Lynne V. Abruzzo, Carmen Herling, George A. Călin, Christopher C. Oakes, Lynn L. Barron, (unknown), (unknown), Michael J. Keating, Kevin R. Coombes	21
3	B-Lymphoblastic Leukemia in Patients With Chronic Lymphocytic Leukemia 2015 ·American Journal of Clinical Pathology ·Zaher Chakhachiro, C. Cameron Yin, Lynne V. Abruzzo, Tariq N. Aladily, Lynn L. Barron, (unknown), Deborah A. Thomas, Michael J. Keating, L. Jeffrey Medeiros, Yang O. Huh	11
4	Genomic Variation by Whole-Genome SNP Mapping Arrays Predicts Time-to-Event Outcome in Patients with Chronic Lymphocytic Leukemia 2012 ·Journal of Molecular Diagnostics ·Carmen D. Schweighofer, Kevin R. Coombes, Tadeusz Majewski, Lynn L. Barron, Susan Lerner, Rachel L. Sargent, Susan O’Brien, Alessandra Ferrajoli, William G. Wierda, Bogdan Czerniak, L. Jeffrey Medeiros, Michael J. Keating, Lynne V. Abruzzo	19
5	LDOC1 mRNA is differentially expressed in chronic lymphocytic leukemia and predicts overall survival in untreated patients 2011 ·Blood ·Hatice Duzkale, Carmen D. Schweighofer, Kevin R. Coombes, Lynn L. Barron, Alessandra Ferrajoli, Susan O’Brien, William G. Wierda, John D. Pfeifer, Tadeusz Majewski, Bogdan Czerniak, Jeffrey L. Jorgensen, L. Jeffrey Medeiros, Emil J. Freireich, Michael J. Keating, Lynne V. Abruzzo	26
6	104 LDOC1 mRNA Is Differentially Expressed in Chronic Lymphocytic Leukemia and Predicts Overall Survival in Untreated Patients 2011 ·Clinical Lymphoma Myeloma & Leukemia* ·Hatice Duzkale, Carmen D. Schweighofer, Kevin R. Coombes, Lynn L. Barron, Emil J. Freireich, Michael J. Keating, Lynne V. Abruzzo	1
7	The B cell antigen receptor in atypical chronic lymphocytic leukemia with t(14;19)(q32;q13) demonstrates remarkable stereotypy 2010 ·International Journal of Cancer ·Carmen D. Schweighofer, Yang O. Huh, Rajyalakshmi Luthra, Rachel L. Sargent, Rhett P. Ketterling, Ryan A. Knudson, Lynn L. Barron, L. Jeffrey Medeiros, Michael J. Keating, Lynne V. Abruzzo	14
8	Array CGH analysis of chronic lymphocytic leukemia reveals frequent cryptic monoallelic and biallelic deletions of chromosome 22q11 that include the PRAME gene 2008 ·Leukemia Research ·Shelly Gunn, (unknown), Lynn L. Barron, M. Gorre, M.H. Afif, David W. Bahler, Clemens Mellink, Marinus H. J. van Oers, Michael J. Keating, Alessandra Ferrajoli, Kevin R. Coombes, Lynne V. Abruzzo, Ryan S. Robetorye	42
9	Array CGH Analysis of Chronic Lymphocytic Leukemia Reveals Frequent Cryptic Monoallelic and Biallelic Deletions of Chromosome 22q11. 2008 ·Blood ·(unknown), Shelly Gunn, (unknown), Lynn L. Barron, M. Gorre, David W. Bahler, Clemens Mellink, Marinus H. J. van Oers, Michael J. Keating, Alessandra Ferrajoli, Kevin R. Coombes, Lynne V. Abruzzo, Ryan S. Robetorye	2
10	Relevance of the immunoglobulin VH somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related chemoimmunotherapy regimens 2008 ·Blood ·Katherine I. Lin, Constantine S. Tam, Michael J. Keating, William G. Wierda, Susan O’Brien, Susan Lerner, Kevin R. Coombes, Ellen Schlette, Alessandra Ferrajoli, Lynn L. Barron, Thomas J. Kipps, Laura Z. Rassenti, Stefan Faderl, Hagop M. Kantarjian, Lynne V. Abruzzo	73
11	Identification and Validation of Biomarkers of IgVH Mutation Status in Chronic Lymphocytic Leukemia Using Microfluidics Quantitative Real-Time Polymerase Chain Reaction Technology 2007 ·Journal of Molecular Diagnostics ·Lynne V. Abruzzo, Lynn L. Barron, K. Anderson, Rachel Newman, William G. Wierda, Susan O’Brien, Alessandra Ferrajoli, Madan G. Luthra, Sameer S. Talwalkar, Rajyalakshmi Luthra, Dan Jones, Michael J. Keating, Kevin R. Coombes	23
12	Biological Validation of Differentially Expressed Genes in Chronic Lymphocytic Leukemia Identified by Applying Multiple Statistical Methods to Oligonucleotide Microarrays 2005 ·Journal of Molecular Diagnostics ·Lynne V. Abruzzo, Jing Wang, Mini Kapoor, L. Jeffrey Medeiros, Michael J. Keating, W. Edward Highsmith, Lynn L. Barron, (unknown), Kevin R. Coombes	10
13	High expression of activation-induced cytidine deaminase (AID) and splice variants is a distinctive feature of poor-prognosis chronic lymphocytic leukemia 2003 ·Blood ·Helen O. McCarthy, William G. Wierda, Lynn L. Barron, (unknown), Jing Wang, Kevin R. Coombes, Roberto Rangel, Kojo S.J. Elenitoba‐Johnson, Michael J. Keating, Lynne V. Abruzzo	120
14	Bovine heart pyruvate dehydrogenase kinase stimulation by alpha-ketoisovalerate. 1990 ·Journal of Biological Chemistry ·John Robertson, Lynn L. Barron, Merle S. Olson	8
15	Bovine heart pyruvate dehydrogenase kinase stimulation by monovalent ions 1989 ·Journal of Biological Chemistry ·John Robertson, Lynn L. Barron, Merle S. Olson	5
16	Stimulation of bovine heart pyruvate dehydrogenase kinase by. cap alpha. -ketoisovalerate in the presence of thiamin pyrophosphate 1987 ·John Robertson, Lynn L. Barron, (unknown)	0
17	The stimulation of hepatic gluconeogenesis by acetoacetate precursors. A role for the monocarboxylate translocator. 1984 ·Journal of Biological Chemistry ·Tarun B. Patel, Lynn L. Barron, Merle S. Olson	27
18	Regulatory effects of fatty acids on decarboxylation of leucine and 4-methyl-2-oxopentanoate in the perfused rat heart 1984 ·Biochemical Journal ·Denis B. Buxton, Lynn L. Barron, (unknown), Merle S. Olson	20
19	The effects of alpha-adrenergic agonists on the regulation of the branched chain alpha-ketoacid oxidation in the perfused rat liver. 1982 ·Journal of Biological Chemistry ·Denis B. Buxton, Lynn L. Barron, Merle S. Olson	28
20	The effect of acetate on the regulation of the branched chain α-keto acid and the pyruvate dehydrogenase complexes in the perfused rat liver 1981 ·Archives of Biochemistry and Biophysics ·Tarun B. Patel, Lynn L. Barron, Merle S. Olson	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact